Business Context and Reporting Period
Company: CalciMedica, Inc. (Nasdaq: CALC)
Filing Type: Form 8-K (Current Report)
Report Date: August 11, 2026
Reporting Period: Fiscal quarter ended June 30, 2026
Context: The filing serves as a notification of the issuance of a press release detailing financial results for the specified quarter. The press release is attached as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover page and index for the Form 8-K and does not contain the specific financial data from the attached press release (Exhibit 99.1). Consequently, the following metrics are not available in the source text:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt Levels
- Liquidity Position
Note: The filing text does not provide a clear value for any specific financial metric.
Material Changes
The filing text does not disclose specific material changes in financial condition or operations compared to prior periods. It only references the announcement of results for the quarter ended June 30, 2026.
Guidance, Outlook, and Risks
The provided text contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. These details are presumed to be contained within the attached Exhibit 99.1 (Press Release), which is not included in the input content.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, net loss, and cash burn figures for the quarter ended June 30, 2026.
- Verify the company's cash runway and liquidity status as of the quarter end.
- Check for any updates on clinical trial progress or regulatory milestones mentioned in the full press release.
- Confirm if there were any changes in the company's capital structure or debt obligations during the period.